Literature DB >> 1331349

Postoperative venous thromboembolism and brain tumors: Part II. Hemostatic profile.

R Sawaya1, P Glas-Greenwalt.   

Abstract

Preoperative hemostatic data were obtained on 42 brain tumor patients and correlated with the subsequent occurrence of venous thrombosis detected with 125I-labeled fibrinogen leg scans. The occurrence of thrombosis correlated significantly with an increased prothrombin time, plasminogen, and total fibrinolytic activity and a decreased fibrinogen level. This overall trend in the group of patients with postoperative thrombosis indicates that the hemostatic disorder noted in brain tumor patients is most closely related to a subclinical form of chronic disseminated intravascular coagulation syndrome. Differences in hemostatic parameters seen with the various types of brain tumors suggest that biological factors specific to each tumor are likely responsible for the described hemostatic disorder and support the need for further research directed at the tumor tissue level.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1331349     DOI: 10.1007/bf00177616

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  35 in total

Review 1.  The role of the fibrinolytic system in thromboembolism.

Authors:  J G Vermylen; D A Chamone
Journal:  Prog Cardiovasc Dis       Date:  1979 Jan-Feb       Impact factor: 8.194

2.  [The help of coagulation tests in preventing thromboembolism in neurosurgery patients (author's transl)].

Authors:  L Tiska-Rudman; G Ledinski
Journal:  Lijec Vjesn       Date:  1976

3.  Alteration in fibrinolysis associated with surgery and venous thrombosis.

Authors:  A O Mansfield
Journal:  Br J Surg       Date:  1972-10       Impact factor: 6.939

4.  [The coagulant and anticoagulant blood systems in brain tumors of supratentorial localization].

Authors:  V V Morozov
Journal:  Zh Nevropatol Psikhiatr Im S S Korsakova       Date:  1968

5.  Fibrinolytic response to surgery. Labile and stable patterns and their relevance to post-operative deep venous thrombosis.

Authors:  M T Knight; R Dawson; D G Melrose
Journal:  Lancet       Date:  1977-08-20       Impact factor: 79.321

6.  Studies on the fibrinolytic system in human plasma: quantitative determination of plasminogen activators and proactivators.

Authors:  C Kluft
Journal:  Thromb Haemost       Date:  1979-04-23       Impact factor: 5.249

7.  [State of the blood coagulation in glial tumors of the brain].

Authors:  G P Burgman; I A Kachkov; I N Vial'tseva; G G Shcherbakova
Journal:  Zh Vopr Neirokhir Im N N Burdenko       Date:  1979 May-Jun

8.  Chronic disseminated intravascular coagulation and metastatic brain tumor: a case report and review of the literature.

Authors:  R Sawaya; J A Donlon
Journal:  Neurosurgery       Date:  1983-05       Impact factor: 4.654

9.  Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor.

Authors:  I M Nilsson; H Ljungnér; L Tengborn
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-18

10.  The role of the fibrinolytic system in deep vein thrombosis.

Authors:  B Wiman; B Ljungberg; J Chmielewska; G Urdén; M Blombäck; H Johnsson
Journal:  J Lab Clin Med       Date:  1985-02
View more
  12 in total

1.  Haemostatic changes during surgery for primary brain tumours.

Authors:  K Y Goh; W C Tsoi; C S Feng; N Wickham; W S Poon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-09       Impact factor: 10.154

2.  Expression of coagulation factors and their receptors in tumor tissue and coagulation factor upregulation in peripheral blood of patients with cerebral carcinoma metastases.

Authors:  Jan Walter; Linn L Handel; Michael Brodhun; Denise van Rossum; Uwe-Karsten Hanisch; Lutz Liebmann; Frank Heppner; Roland Goldbrunner; Arend Koch; Susanne A Kuhn
Journal:  J Cancer Res Clin Oncol       Date:  2011-11-08       Impact factor: 4.553

3.  Risk factors for venous thromboembolism in patients undergoing craniotomy for neoplastic disease.

Authors:  Kristopher T Kimmell; Kevin A Walter
Journal:  J Neurooncol       Date:  2014-08-23       Impact factor: 4.130

4.  A prospective multicenter study of venous thromboembolism in patients with newly-diagnosed high-grade glioma: hazard rate and risk factors.

Authors:  Michael B Streiff; Xiaobu Ye; Thomas S Kickler; Serena Desideri; Jayesh Jani; Joy Fisher; Stuart A Grossman
Journal:  J Neurooncol       Date:  2015-06-23       Impact factor: 4.130

5.  Predictors of Venous Thromboembolism After Nonemergent Craniotomy: A Nationwide Readmission Database Analysis.

Authors:  Ian A Buchanan; Michelle Lin; Daniel A Donoho; Arati Patel; Li Ding; Arun P Amar; Steven L Giannotta; William J Mack; Frank Attenello
Journal:  World Neurosurg       Date:  2018-11-20       Impact factor: 2.104

6.  Risk of post-operative venous thromboembolism in patients with meningioma.

Authors:  Giorgio Carrabba; Marco Riva; Valeria Conte; Andrea Di Cristofori; Manuela Caroli; Marco Locatelli; Massimo Castellani; Paolo Bucciarelli; Andrea Artoni; Nino Stocchetti; Ida Martinelli; Paolo Rampini
Journal:  J Neurooncol       Date:  2018-03-02       Impact factor: 4.130

7.  Thromboembolic disease in patients with high-grade glioma.

Authors:  James R Perry
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

8.  Critically ill cancer patients are not consistently hypercoagulable after craniotomy.

Authors:  Joseph L Nates; Natarajan Aravindan; Cheryl Hirsch-Ginsberg; Kurt C Sizer; Spencer Kee; Anh T Nguyen; Karen Chen; Andrew D Shaw; Kristen J Price
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

Review 9.  Thromboembolic complications associated with brain tumors.

Authors:  R E Sawaya; B L Ligon
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 10.  Activities, localizations, and roles of serine proteases and their inhibitors in human brain tumor progression.

Authors:  M Yamamoto; R Sawaya; S Mohanam; V H Rao; J M Bruner; G L Nicolson; K Ohshima; J S Rao
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.